A novel device to assess the oxygen saturation and congestion status of the gastric conduit in thoracic esophagectomy

Takeo Fujita,Takashi Shigeno,Daisuke Kajiyama,Kazuma Sato,Naoto Fujiwara,Hiroyuki Daiko
DOI: https://doi.org/10.1186/s12893-023-02303-0
2024-01-09
BMC Surgery
Abstract:In thoracic esophagectomy, anastomotic leakage is one of the most important surgical complications. Indocyanine green (ICG) is the most widely used method to assess tissue blood flow; however, this technique has been pointed out to have disadvantages such as difficulty in evaluating the degree of congestion, lack of objectivity in evaluating the degree of staining, and bias easily caused by ICG injection, camera distance, and other factors.
surgery
What problem does this paper attempt to address?
The problem that this paper attempts to solve is how to more accurately assess the blood flow condition of the gastric tube during thoracic esophagectomy in order to determine the optimal anastomotic site and predict potential anastomotic leakage. Specifically, the paper explores a new device - the Toccare™ device. By analyzing tissue oxygen saturation (StO2) and total hemoglobin index (T - HbI), it overcomes the shortcomings of the traditional indocyanine green (ICG) imaging technique in assessing tissue blood flow, such as difficulty in assessing the degree of congestion, lack of objectivity, and being easily affected by factors such as ICG injection and camera distance. ### Research Background During thoracic esophagectomy, anastomotic leakage is one of the most serious surgical complications, which can lead to prolonged postoperative hospital stay, increased medical costs, and affect the patient's quality of life and prognosis. Currently, indocyanine green (ICG) imaging is the most commonly used method for assessing tissue blood flow, but this method has some limitations, such as difficulty in quantifying the degree of congestion and strong subjectivity. Therefore, it is particularly important to develop a new method that can assess tissue blood flow and congestion in real - time and objectively. ### Research Purpose The purpose of this study is to evaluate the effectiveness of a new blood flow assessment device (Toccare™ device) in assessing the blood flow of the gastric tube during thoracic esophagectomy, especially in determining the optimal anastomotic site and predicting potential anastomotic leakage. ### Methods The study included 50 esophageal cancer patients who underwent thoracic esophagectomy. Among them, 7 were excluded due to intraoperative findings, and finally the data of 43 patients were analyzed. During the operation, the Toccare™ device was used to assess the tissue oxygen saturation (StO2) and total hemoglobin index (T - HbI) of the gastric tube, and relevant data were recorded. The primary endpoints of the study were the effectiveness, safety, and quantitative value of the Toccare™ device in assessing the blood flow of the gastric tube, and the secondary endpoints included postoperative complications and the results of gastric tube reconstruction. ### Results The study found that StO2 decreased significantly at the distal end of the right gastroepiploic artery (RGEA) (p < 0.05), and T - HbI also decreased significantly at the distal end of the RGEA (p < 0.05). In the 3 patients with anastomotic leakage, StO2 was significantly lower (p < 0.01) and T - HbI was significantly higher (p < 0.01) at the end and demarcation line of the RGEA. In addition, the anastomotic site was usually within 3 cm of the anal side of the RGEA, and StO2 and T - HbI at these positions were also significantly lower and higher in patients with anastomotic leakage (p < 0.01). ### Conclusions The new device provides real - time and objective assessment of gastric tube blood flow and congestion, which is helpful for safer reconstruction during thoracic esophagectomy, especially by identifying the optimal anastomotic site and predicting potential anastomotic leakage. This provides a new tool for improving the success rate of surgery and reducing postoperative complications.